Athauda, D; Foltynie, T; (2016) The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action. Drug Discovery Today , 21 (5) pp. 802-818. 10.1016/j.drudis.2016.01.013. Green open access